FBLG FibroBiologics, Inc. - Common Stock
$1.20
Price · Aug 19, 2026
Fundamentals as of Jul 31, 2026
52W Range
$0–$5
19% of range
Analyst Rating
BUY
7 analysts
Price Target
$12
+946% upside
P/E (TTM)
-0.5
ROE
—
Net Profit Margin
—
FBLG Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.20
Market Cap
—
P/E (TTM)
-0.5
EPS (TTM)
$-0.42
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $5
FBLG Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-0.42
2022-12-31
→
2025-12-31
Free Cash Flow
—
2023-12-31
→
2024-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
FBLG
Peer Median
P/E (TTM)
-0.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
FBLG
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
FBLG
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
FBLG
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
FBLG
Peer Median
FBLG Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-19
Median
$12.50
← Below all targets
$1.20
Low
$6.00
High
$19.00
Median target
$12.50
+946.0%
Mean target
$12.50
+946.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.03%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.66 | $-0.73 | 0.07% |
| March 31, 2026 | $-1.33 | $-1.33 | -0.00% |
| Dec. 31, 2025 | $-0.60 | $-1.78 | 1.2% |
| Sept. 30, 2025 | $-2.60 | $-2.19 | -0.41% |
| June 30, 2025 | $-2.40 | $-2.29 | -0.10% |
| March 31, 2025 | $-2.80 | $-2.24 | -0.56% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| FBLG | — | -0.5 | — | — | — | — |
| IMNN | $13M | -0.6 | — | — | -298.2% | — |
| APRE | $7M | -0.4 | — | — | -97.5% | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| CELZ | — | -0.8 | -45.5% | — | — | — |
| ALZN | $5M | -0.4 | — | — | -598.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $7M | $5M | $2M | $1M | |
| SG&A Expense | $9M | $9M | $7M | $3M | |
| Operating Expenses | $17M | $14M | $9M | $4M | |
| Operating Income | $-17M | $-14M | $-9M | $-4M | |
| Interest Expense | · | · | $147.0K | $654.0K | |
| Interest Income | $247.0K | $251.0K | · | · | |
| Other Non-op | $-619.0K | $32.0K | $-213.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-11M | $-16M | $-5M | |
| EPS (Basic) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| EPS (Diluted) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| Shares (Basic) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| EBITDA | · | $-14M | $-9M | · |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $14M | $9M | $2M | |
| Receivables | · | · | · | $300.0K | |
| Prepaid Expense | $1M | $225.0K | $36.0K | $29.0K | |
| Other Current Assets | $0 | $18.0K | $16.0K | $30.0K | |
| Current Assets | $6M | $14M | $9M | $3M | |
| PP&E (Net) | $842.0K | $824.0K | $797.0K | · | |
| PP&E (Gross) | $1M | $1M | $844.0K | · | |
| Accum. Depreciation | $448.0K | $204.0K | $47.0K | · | |
| Total Assets | $10M | $16M | $12M | $5M | |
| Accounts Payable | $945.0K | $3M | $1M | $758.0K | |
| Short-term Debt | $0 | $9M | · | · | |
| Current Liabilities | $2M | $13M | $9M | $7M | |
| Capital Leases | $2M | $984.0K | $1M | $2M | |
| Total Liabilities | $3M | $14M | $11M | $9M | |
| Common Stock | $1.0K | $0 | · | · | |
| Paid-in Capital | $60M | $38M | $26M | $2M | |
| Retained Earnings | $-54M | $-36M | $-24M | $-8M | |
| Stockholders' Equity | $6M | $3M | $1M | $-4M | |
| Liabilities + Equity | $10M | $16M | $12M | $5M |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $265.0K | |
| Operating Cash Flow | $-16M | $-12M | $-6M | $-4M | |
| CapEx | $262.0K | $184.0K | $495.0K | · | |
| Investing Cash Flow | $-262.0K | $-184.0K | $-495.0K | · | |
| Stock Issued | $7M | $8M | · | · | |
| Net Stock Activity | · | $8M | · | · | |
| Financing Cash Flow | $8M | $17M | $14M | $6M | |
| Net Change in Cash | $-9M | $5M | $7M | $2M | |
| Taxes Paid | $0 | $0 | · | · | |
| Free Cash Flow | · | $-12M | $-7M | · |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | -79.0% | -198.1% | · | |
| ROE | · | -407.9% | -279.6% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | 1.0 | · | |
| Quick Ratio | · | 1.1 | 1.0 | · | |
| Interest Coverage | · | · | -60.5 | · |
Valuation (TTM) 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-11M | $-16M | · | |
| P/E | -0.5 | -5.9 | · | · | |
| Earnings Yield | -186.7% | -17.0% | · | · |
Income Statement 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $797.0K | $3M | $2M | $2M | $1M | $1M | $975.0K | $960.0K | $772.0K | $547.0K | $478.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $5M | $3M | $5M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Operating Income | $-4M | $-5M | $-3M | $-5M | $-4M | $-5M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $5.0K | $4.0K | · | $10.0K | $135.0K | |
| Interest Income | $15.0K | $20.0K | $25.0K | $73.0K | $50.0K | $99.0K | $63.0K | $79.0K | $70.0K | $39.0K | · | · | · | |
| Other Non-op | $-92.0K | $-2.0K | $6.0K | $0 | $-625.0K | $0 | $1.0K | $2.0K | $30.0K | · | $0 | $-57.0K | $-15.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-6M | $-5M | $-5M | $-3M | $-500.0K | $898.0K | $-8M | $-10M | $-2M | $-2M | |
| EPS (Basic) | $-0.66 | $-1.33 | $-0.03 | $-0.13 | $-2.41 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| EPS (Diluted) | $-0.66 | $-1.33 | $-0.03 | $-0.13 | $-2.41 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| Shares (Basic) | 6,272,541 | 3,772,930 | -73,720,414 | 43,072,542 | 1,931,763 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 6,272,541 | 3,772,930 | -73,720,414 | 43,072,542 | 1,931,763 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| EBITDA | $-4M | $-5M | · | $-5M | $-4M | $-5M | · | $-3M | $-3M | $-3M | · | · | · |
Balance Sheet 19
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $1M | $5M | $5M | $9M | $9M | $14M | $8M | $6M | $8M | $9M | · | · | |
| Prepaid Expense | $528.0K | $1M | $1M | $373.0K | $1M | $642.0K | $225.0K | $353.0K | $518.0K | $746.0K | $36.0K | · | · | |
| Other Current Assets | · | $403.0K | $0 | · | · | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $16.0K | · | · | |
| Current Assets | $6M | $3M | $6M | $5M | $10M | $9M | $14M | $8M | $7M | $9M | $9M | · | · | |
| PP&E (Net) | $710.0K | $776.0K | $842.0K | $908.0K | $967.0K | $814.0K | $824.0K | $772.0K | $799.0K | $770.0K | $797.0K | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $929.0K | $918.0K | $852.0K | $844.0K | · | · | |
| Accum. Depreciation | $580.0K | $514.0K | $448.0K | $382.0K | $317.0K | $257.0K | $204.0K | $157.0K | $119.0K | $82.0K | $47.0K | · | · | |
| Total Assets | $8M | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · | |
| Accounts Payable | $2M | $850.0K | $945.0K | $1M | $2M | $1M | $3M | $1M | $1M | $814.0K | $1M | · | · | |
| Short-term Debt | · | · | $0 | $5M | $8M | $6M | $9M | $115.0K | $287.0K | $459.0K | · | · | · | |
| Current Liabilities | $2M | $2M | $2M | $7M | $11M | $8M | $13M | $7M | $10M | $14M | $9M | · | · | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $865.0K | $984.0K | $1M | $1M | $1M | $1M | · | · | |
| Total Liabilities | $3M | $3M | $3M | $9M | $13M | $9M | $14M | $8M | $11M | $15M | $11M | · | · | |
| Total Debt | · | · | · | $5M | $8M | $6M | · | $115.0K | $287.0K | $459.0K | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $0 | $0 | · | $0 | · | · | · | · | · | · | |
| Paid-in Capital | $68M | $62M | $60M | $51M | $46M | $43M | $38M | $35M | $30M | $29M | $26M | · | · | |
| Retained Earnings | $-63M | $-59M | $-54M | $-51M | $-45M | $-40M | $-36M | $-32M | $-32M | $-33M | $-24M | · | · | |
| Stockholders' Equity | $5M | $3M | $6M | $125.0K | $860.0K | $2M | $3M | $3M | $-2M | $-4M | $1M | · | · | |
| Liabilities + Equity | $8M | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $707.0K | $694.0K | $702.0K | $704.0K | $729.0K | $551.0K | $544.0K | $572.0K | $578.0K | $525.0K | $432.0K | $448.0K | $448.0K | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | |
| CapEx | $0 | $0 | $0 | $6.0K | $213.0K | $43.0K | $99.0K | $11.0K | $66.0K | $8.0K | $2.0K | $24.0K | $56.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $-6.0K | $-213.0K | $-43.0K | $-99.0K | $-11.0K | $-66.0K | $-8.0K | $-2.0K | $-24.0K | $-56.0K | |
| Stock Issued | $3M | $706.0K | · | · | $0 | $0 | $45.0K | $5M | $0 | $3M | · | · | · | |
| Net Stock Activity | · | $706.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $952.0K | $3M | $0 | $4M | $0 | $9M | $4M | $-172.0K | $3M | $0 | $-2M | $15M | |
| Net Change in Cash | $2M | $-3M | $27.0K | $-4M | $178.0K | $-5M | $6M | $2M | $-2M | $-1M | $-2M | $-3M | $12M | |
| Taxes Paid | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-4M | · | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -37.7% | -57.6% | · | -60.2% | -40.8% | -43.5% | · | -9.6% | 20.2% | -148.4% | · | · | · | |
| ROE | -149.8% | -202.0% | · | -403.8% | 610.1% | 656.4% | · | -36.5% | -75.2% | 438.0% | · | · | · |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 1.6 | · | 0.8 | 0.9 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Quick Ratio | 1.6 | 0.8 | · | 0.7 | 0.8 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Debt / Equity | · | · | · | 36.6 | 9.4 | 2.5 | · | 0.0 | -0.1 | -0.1 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -644.8 | -862.5 | · | · | · |
Valuation (TTM) 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-20M | $-20M | · | $-16M | $-9M | $-13M | · | $-10M | $-12M | $-15M | · | · | · | |
| P/E | -0.2 | -0.3 | · | -1.4 | -2.6 | -2.3 | · | -9.4 | -12.5 | -17.7 | · | · | · | |
| Earnings Yield | -477.9% | -325.0% | · | -73.3% | -38.6% | -43.3% | · | -10.7% | -8.0% | -5.6% | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Net Income | $-19M | $-11M | $-16M | $-5M |
| Diluted EPS | $-0.42 | $-0.34 | $-0.68 | $-0.18 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Current Ratio | — | 1.1 | 1.0 | — |
| Quick Ratio | — | 1.1 | 1.0 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Free Cash Flow | — | $-12M | $-7M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 2 filers · $71K total · As of Dec. 31, 2025
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q4 2025 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-2 vs prior Q) | 13 (+1 vs prior Q) | 5 (-2 vs prior Q) | 6 (-15 vs prior Q) | -472K |
Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Nuveen Asset Management, LLC | $69,080 | 34,540 | 96.62% | Shares |
| VANGUARD GROUP INC | $2,416 | 10,736 | 3.38% | Shares |
Company insiders 4 insiders · 0 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Victoria Ninon Olivia Niklas | Director | June 23, 2026 A | — | 0 | 0 | $0 |
| Richard C. Cilento Jr. | Director | June 23, 2026 A | — | 0 | 0 | $0 |
| Matthew Link | Director | June 23, 2026 A | — | 0 | 0 | $0 |
| Robert Hoffman | Director | June 23, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |